More General News
View Older Stories View Newer Stories-
Exclusive: French bankers seek EU law to move euro clearing from London - sources
-
Target to invest $4 billion annually to cement pandemic market share gains
-
Biden says will have enough COVID-19 vaccine for every U.S. adult by May
-
OPEC president says oil market rebalancing, pandemic still a risk
-
U.S. imposes sanctions on Russia over poisoning of Navalny
-
Wix.com buys SpeedETab to strengthen restaurants platform
-
Facebook Oversight Board changes timeline rules for action on case appeals
-
Online demand fuels Abercrombie & Fitch profit beat, rosy sales outlook
-
Google teams up with Allianz, Munich Re to insure its cloud users
-
Canopy launches CBD-infused sparkling water line in United States
-
Exclusive: India woos Tesla with offer of cheaper production costs than China
-
Wall Street ends lower as Apple and Tesla retreat
-
BlackRock still backing stocks after bond market turbulence
-
Hertz set to ride out of bankruptcy with $4.2 billion from investment firms
-
Target to spend $4 billion a year to speed up delivery as pandemic spurs online gains
-
Bond selloff eases but risk gauges flash orange
-
Emerging markets see $31.2 billion in non-resident flows in February: IIF
-
China's Ant seeks to ease staff concerns about selling company's shares
-
Bitcoin rises 8% to $48,861.48
-
Novavax COVID-19 shot could be cleared for U.S. use by May: CEO
-
Zoom shares rise on strong current-quarter forecast, upbeat results
-
GameStop surges more than 18%, other 'meme stocks' also rally
-
Twitter tackles COVID-19 vaccine misinformation with labels, strike policy
-
NFL's JJ Watt tweets pic with Arizona Cardinals shirt
-
Exclusive: Goldman Sachs restarts cryptocurrency desk amid bitcoin boom
-
Global COVID-19 infections up for first time in seven weeks, WHO says
-
U.S. FTC tells e-cigarette firms JUUL, NJOY, others to submit sales, ad data
-
Workhorse to meet USPS on Wednesday to discuss loss of delivery contract
-
Over 60% of Russians don't want Sputnik V vaccine, see coronavirus as biological weapon: Reuters poll
-
Goldman Sachs' co-head of asset management leaves for Tiger Global
-
Apple's 270 U.S. stores all open for first time since pandemic began
-
Construction spending hits record high in January
-
Analysis: Emerging markets feel the heat of the 'bondfire'
-
SoftBank to write down $1.5 billion Greensill investment: Bloomberg News
-
Exxon names Ubben, Angelakis to board amid investor pressure for change
-
U.S. investigates nearly 1.9 million Toyota RAV4s over fire risks
-
Twilio to invest up to $750 million in telecom company Syniverse
-
Chinese blockchain firm SOS denies allegations by short-sellers
-
MicroStrategy bitcoin holding valued at $4.38 billion after latest buy
-
Flowserve supplying pumps, valves for Pfizer vaccine production
-
Tyson to offer vaccinations to thousands of Iowa meat plant workers
-
Global bond markets rally as RBA ups bond buys, ECB official urges action to curb rate rise
-
Beyond Meat CFO Mark Nelson to retire
-
Analysis: SPACs turn to 'stonks' as amateur traders take on more risk
-
McKesson begins distribution of Johnson & Johnson's COVID-19 vaccine
-
Polaris to launch its first electric vehicle
-
NFL denies report on media rights deal with Disney
-
U.S. SEC suspends trading in 15 securities due to 'questionable' social media activity
-
SEC Suspends Trading in Multiple Issuers Based on Social Media and Trading Activity
-
U.S. regulators probe Robinhood over trading curbs
